EM-113

N/A

Report date: 2024/07/26 17:21:31
NME

Base Information

Drug NameEM-113
Drug Alias NameEM-113
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsAutism Spectrum Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMochda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEumentis Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAutism Spectrum Disorder
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A